QIAGEN Appoints Mark Stevenson to Supervisory Board

Mark Stevenson appointed as independent member of QIAGEN's Supervisory Board effective January 23, 2026, to stand for election at June 2026 AGM.13

Prof. Dr. Ross Levine stepped down from Supervisory Board on January 23, 2026, to become Chief Scientific Officer at Memorial Sloan Kettering Cancer Center; remains Chair of QIAGEN Scientific Advisory Board.13

Stevenson has over 30 years in life sciences, former EVP and COO at Thermo Fisher Scientific, COO at Life Technologies and Applied Biosystems; currently Operating Partner at Fivespan Partners and board member at Ingersoll Rand.13

Stephen H. Rusckowski, Chairman, praised Stevenson's operational leadership and global experience.13

Supervisory Board now has eight members:
Stephen H. Rusckowski (Chairman), Dr. Metin Colpan, Dr. Toralf Haag, Bert van Meurs, Eva van Pelt, Dr. Eva Pisa, Mark Stevenson, Elizabeth E. Tallett.13

Sources:

1. https://www.businesswire.com/news/home/20260126460580/en/QIAGEN-Appoints-Mark-Stevenson-to-Supervisory-Board

3. https://investingnews.com/qiagen-appoints-mark-stevenson-to-supervisory-board/